Healthcare - Biotechnology - NASDAQ - US
$ 1.13
-1.74 %
$ 5.07 M
Market Cap
-0.97
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--2.92%
EBIT
Estimate
98.91%
Net Income
Estimate
41.74%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Silo Pharma, Inc.
SILO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SILO
EBIT FORECAST
EBIT Forecast Chart SILO
NET INCOME FORECAST
Net Income Chart SILO